All Stories

  1. At Early Rheumatoid Arthritis Stage, the Infectious Spectrum Is Driven by Non-Familial Factors and Anti-CCP Immunization

    Article • Journal of Clinical Medicine, May 2024, MDPI AG

    yves Renaudineau

  2. Blocking Orai1 constitutive activity inhibits B-cell cancer migration and synergistically acts with drugs to reduce B-CLL cell survival

    Article • European Journal of Pharmacology, May 2024, Elsevier

    yves Renaudineau

  3. Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus

    Article • Clinical Immunology, May 2024, Elsevier

    yves Renaudineau

  4. Not just another klass (JAK) of inhibitors for allergies

    Article • Journal of Allergy and Hypersensitivity Diseases, January 2024, Elsevier

    yves Renaudineau

  5. Orai1 Ca2+ channel modulators as therapeutic tools for treating cancer: Emerging evidence!

    Article • Biochemical Pharmacology, January 2024, Elsevier

    yves Renaudineau

  6. Low performance of interferon gamma release assay Quantiferon-TB gold coupled or not with Pst1/3/lipoglycan humoral detection to predict Mycobacterium tuberculosis complex disease in a low-burden area

    Article • Tuberculosis, December 2023, Elsevier

    yves Renaudineau

  7. Lupus Nephritis Risk Factors and Biomarkers: An Update

    Article • International Journal of Molecular Sciences, September 2023, MDPI AG

    yves Renaudineau

  8. Characteristics of the (Auto)Reactive T Cells in Rheumatoid Arthritis According to the Immune Epitope Database

    Article • International Journal of Molecular Sciences, February 2023, MDPI AG

    yves Renaudineau

  9. Glucocorticoids selectively affect the memory T cell response to SARS-Cov2 spike in vaccinated and post-infected patients with systemic lupus erythematosus

    Article • Journal of Translational Autoimmunity, January 2023, Elsevier

    yves Renaudineau

  10. Immunological and translational key challenges in systemic lupus erythematosus: A symposium update

    Article • Journal of Translational Autoimmunity, January 2023, Elsevier

    yves Renaudineau

  11. Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseases

    Article • Journal of Autoimmunity, December 2022, Elsevier

    yves Renaudineau

  12. Anti-Citrullinated Peptide Antibodies Control Oral Porphyromonas and Aggregatibacter species in Patients with Rheumatoid Arthritis

    Article • International Journal of Molecular Sciences, October 2022, MDPI AG

    yves Renaudineau

  13. Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study

    Article • Frontiers in Pharmacology, September 2022, Frontiers

    yves Renaudineau

  14. The oxygen carrier M101 alleviates complement activation, which may be beneficial for donor organ preservation

    Article • Frontiers in Immunology, September 2022, Frontiers

    yves Renaudineau

  15. Editorial: Epigenetic aspects of autoimmune diseases

    Article • Frontiers in Cell and Developmental Biology, August 2022, Frontiers

    yves Renaudineau

  16. Kappa-index: Real-life evaluation of a new tool for multiple sclerosis diagnosis

    Article • Clinical Immunology, August 2022, Elsevier

    yves Renaudineau

  17. Myositis-specific autoantibodies in clinical practice: Improving the performance of the immunodot

    Article • Seminars in Arthritis and Rheumatism, August 2022, Elsevier

    yves Renaudineau

  18. Interplay of Environmental, Individual and Genetic Factors in Rheumatoid Arthritis Provocation

    Article • International Journal of Molecular Sciences, July 2022, MDPI AG

    yves Renaudineau

  19. Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study

    Article • Journal of Cystic Fibrosis, May 2022, Elsevier

    yves Renaudineau

  20. Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response

    Article • Clinical Immunology, April 2022, Elsevier

    yves Renaudineau

  21. Possible mechanism of the implementing the trigger role of air pollution in rheumatoid arthritis (preliminary data)

    Article • Hygiene and Sanitation, March 2022, Federal Scientific Center for Hygiene F.F.Erisman

    yves Renaudineau

  22. Long non-coding RNA Xist contribution in systemic lupus erythematosus and rheumatoid arthritis

    Article • Clinical Immunology, March 2022, Elsevier

    yves Renaudineau

  23. Altered DNA methylation pattern characterizes the peripheral immune cells of patients with autoimmune hepatitis

    Article • Liver International, February 2022, Wiley

    yves Renaudineau

  24. Lupus band test can be used in combination with anti-chromatin antibodies and complement analysis to predict transition from cutaneous to systemic lupus

    Article • Clinical Immunology, January 2022, Elsevier

    yves Renaudineau

  25. Provocation of oxidative stress by heavy metals as a possible trigger factor in the development of rheumatoid arthritis

    Article • Molekulyarnaya Meditsina (Molecular medicine), January 2022, Russkiy Vrach Publishing House

    yves Renaudineau

  26. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases

    Article • Journal of Translational Autoimmunity, January 2022, Elsevier

    yves Renaudineau

  27. Editorial: Role of Macrophage MicroRNAs in Inflammatory Diseases and Cancer

    Article • Frontiers in Immunology, September 2021, Frontiers

    yves Renaudineau

  28. Combining multi-antigenic immunodot with indirect immunofluorescence on HEp-2 cells improves the diagnosis of systemic sclerosis

    Article • Clinical Immunology, August 2021, Elsevier

    yves Renaudineau

  29. Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia

    Article • Journal of Leukocyte Biology, July 2021, Wiley

    yves Renaudineau

  30. A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases

    Article • Arthritis & Rheumatology, July 2021, Wiley

    yves Renaudineau

  31. Altered DNA methylation pattern characterizes the peripheral immune cells of patients with autoimmune hepatitis

    Article • July 2021, Cold Spring Harbor Laboratory Press

    yves Renaudineau

  32. Tocilizumab controls bone turnover in early polymyalgia rheumatica

    Article • Joint Bone Spine, May 2021, Elsevier

    yves Renaudineau

  33. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

    Article • Arthritis & Rheumatology, April 2021, Wiley

    yves Renaudineau

  34. Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade

    Article • Rheumatology and Therapy, March 2021, Springer Science + Business Media

    yves Renaudineau

  35. An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases

    Article • Journal of Translational Autoimmunity, January 2021, Elsevier

    yves Renaudineau

  36. Causal risk and protective factors in rheumatoid arthritis: A genetic update

    Article • Journal of Translational Autoimmunity, January 2021, Elsevier

    yves Renaudineau

  37. Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases

    Article • Journal of Autoimmunity, December 2020, Elsevier

    yves Renaudineau

  38. CD5 and B lymphocyte responses: multifaceted effects through multitudes of pathways and channels

    Article • Cellular and Molecular Immunology, July 2020, Springer Science + Business Media

    yves Renaudineau

  39. Évaluation de la taille des glandes salivaires majeures dans le syndrome de Gougerot-Sjögren primitif : comparaison de l’examen clinique et de l’échographie

    Article • Revue du Rhumatisme, July 2020, Elsevier

    yves Renaudineau

  40. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

    Article • February 2020, Cold Spring Harbor Laboratory Press

    yves Renaudineau

  41. Epigenetics in Primary Sjögren’s Syndrome

    Article • January 2020, Springer Science + Business Media

    yves Renaudineau

  42. Linking genetic variation with epigenetic profiles in Sjögren's syndrome

    Article • Clinical Immunology, January 2020, Elsevier

    yves Renaudineau

  43. JAK Inhibitors and Oxidative Stress Control

    Article • Frontiers in Immunology, December 2019, Frontiers

    yves Renaudineau

  44. Assessment of major salivary gland size in primary Sjögren's syndrome: Comparison between clinical examination and ultrasonography

    Article • Joint Bone Spine, October 2019, Elsevier

    yves Renaudineau

  45. Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren’s Syndrome and Primary Biliary Cholangitis

    Article • Epigenomes, August 2019, MDPI AG

    yves Renaudineau

  46. News and meta-analysis regarding anti-Beta 2 glycoprotein I antibodies and their determination

    Article • Clinical Immunology, August 2019, Elsevier

    yves Renaudineau

  47. Innate B Cells: the Archetype of Protective Immune Cells

    Article • Clinical Reviews in Allergy & Immunology, June 2019, Springer Science + Business Media

    yves Renaudineau

  48. JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren’s Syndrome

    Article • Clinical Reviews in Allergy & Immunology, June 2019, Springer Science + Business Media

    yves Renaudineau

  49. The Innate Part of the Adaptive Immune System

    Article • Clinical Reviews in Allergy & Immunology, June 2019, Springer Science + Business Media

    yves Renaudineau

  50. Complement System: a Neglected Pathway in Immunotherapy

    Article • Clinical Reviews in Allergy & Immunology, May 2019, Springer Science + Business Media

    yves Renaudineau

  51. Toll-Like Receptors, Infections, and Rheumatoid Arthritis

    Article • Clinical Reviews in Allergy & Immunology, May 2019, Springer Science + Business Media

    yves Renaudineau

  52. STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia

    Article • Journal for ImmunoTherapy of Cancer, April 2019, Springer Science + Business Media

    yves Renaudineau

  53. Editorial: Shaping of Human Immune System and Metabolic Processes by Viruses and Microorganisms

    Article • Frontiers in Microbiology, April 2019, Frontiers

    yves Renaudineau

  54. Apoptotic resistance in chronic lymphocytic leukemia and therapeutic perspectives

    Article • Critical Reviews in Clinical Laboratory Sciences, April 2019, Taylor & Francis

    yves Renaudineau, Dr Wesley H Brooks

  55. Psychological stress and rheumatoid arthritis – interference of pathogenetic mechanisms

    Article • Rheumatology Science and Practice, March 2019, IMA Press, LLC

    yves Renaudineau

  56. In seroconverted rheumatoid arthritis patients a multi-reactive anti-herpes IgM profile is associated with disease activity

    Article • Clinical Immunology, March 2019, Elsevier

    yves Renaudineau

  57. Peripheral-blood b-cell subset disturbances in inflammatory joint diseases induced by Tropheryma whipplei

    Article • PLoS ONE, February 2019, PLOS

    yves Renaudineau

  58. Rapid and complete response to idelalisib in a case of Richter syndrome

    Article • OncoTargets and Therapy, February 2019, Dove Medical Press

    yves Renaudineau

  59. 17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia

    Article • Journal for ImmunoTherapy of Cancer, January 2019, Springer Science + Business Media

    yves Renaudineau

  60. A Pathogenic Cytokine Network Is Associated with Pro-Inflammatory B Cells in Systemic Lupus Erythematosus Patients

    Article • SSRN Electronic Journal, January 2019, Elsevier

    yves Renaudineau

  61. Microbiota analysis in rheumatoid arthritis: News and perspectives

    Article • Clinical Microbiology and Infectious Diseases, January 2019, Open Access Text Pvt, Ltd.

    yves Renaudineau

  62. The regulatory capacity of B cells directs the aggressiveness of CLL

    Article • OncoImmunology, December 2018, Taylor & Francis

    yves Renaudineau

  63. Prevalence and Incidence of Upper Respiratory Tract Infection Events Are Elevated Prior to the Development of Rheumatoid Arthritis in First-Degree Relatives

    Article • Frontiers in Immunology, November 2018, Frontiers

    yves Renaudineau

  64. Thrombotic risk assessment and analytical performance of the chemiluminescent analyzer IDS-iSYS for the detection of anti-cardiolipin and anti-beta 2 glycoprotein I autoantibodies

    Article • Clinical Immunology, September 2018, Elsevier

    yves Renaudineau

  65. Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy

    Article • Oncotarget, June 2018, Impact Journals, LLC

    yves Renaudineau

  66. Épigénome et syndrome de Gougerot-Sjögren

    Article • La Revue de Médecine Interne, May 2018, Elsevier

    yves Renaudineau

  67. DNA demethylation marks in chronic lymphocytic leukemia: it is time to let the cat out of the bag

    Article • Future Science OA, February 2018, Future Science

    yves Renaudineau

  68. Clinical Characteristics of Pruritus in Systemic Sclerosis Vary According to the Autoimmune Subtype

    Article • Acta Dermato Venereologica, January 2018, Acta Dermato-Venereologica

    yves Renaudineau

  69. Associations between Viral Infection History Symptoms, Granulocyte Reactive Oxygen Species Activity, and Active Rheumatoid Arthritis Disease in Untreated Women at Onset: Results from a Longitudinal Cohort Study of Tatarstan Women

    Article • Frontiers in Immunology, December 2017, Frontiers

    yves Renaudineau

  70. Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren’s syndrome

    Article • December 2017, Springer Science + Business Media

    yves Renaudineau

  71. Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion

    Article • Clinical Epigenetics, November 2017, Springer Science + Business Media

    yves Renaudineau

  72. Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia

    Article • Oncotarget, August 2017, Impact Journals, LLC

    yves Renaudineau

  73. Constitutive calcium entry and cancer: updated views and insights

    Article • European Biophysics Journal, May 2017, Springer Science + Business Media

    yves Renaudineau

  74. Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.

    Article • Clinical Reviews in Allergy & Immunology, May 2017, Springer Science + Business Media

    yves Renaudineau

  75. Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus

    Article • Clinical Reviews in Allergy & Immunology, May 2017, Springer Science + Business Media

    yves Renaudineau

  76. Immunophenotyping As a New Tool for Classification and Monitoring of Systemic Autoimmune Diseases

    Article • Clinical Reviews in Allergy & Immunology, May 2017, Springer Science + Business Media

    yves Renaudineau

  77. Memory B Cells and Response to Abatacept in Rheumatoid Arthritis

    Article • Clinical Reviews in Allergy & Immunology, May 2017, Springer Science + Business Media

    yves Renaudineau

  78. Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity

    Article • Clinical Reviews in Allergy & Immunology, April 2017, Springer Science + Business Media

    yves Renaudineau

  79. Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica

    Article • Rheumatology, April 2017, Oxford University Press (OUP)

    yves Renaudineau

  80. Molecular Dynamics Simulations of Membrane-Bound STIM1 to Investigate Conformational Changes during STIM1 Activation upon Calcium Release

    Article • Journal of Chemical Information and Modeling, February 2017, American Chemical Society (ACS)

    yves Renaudineau

  81. Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sjögren's syndrome

    Article • Annals of the Rheumatic Diseases, January 2017, BMJ

    yves Renaudineau

  82. Isolated Cardiac Richter Syndrome: a Case Report

    Article • Annals of Hematology, October 2016, Springer Science + Business Media

    yves Renaudineau

  83. DNA methylation signatures in Sjögren syndrome

    Article • Nature Reviews Rheumatology, September 2016, Springer Science + Business Media

    yves Renaudineau

  84. How Rheumatoid Arthritis Can Result from Provocation of the Immune System by Microorganisms and Viruses

    Article • Frontiers in Microbiology, August 2016, Frontiers

    yves Renaudineau

  85. CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes

    Article • Cellular and Molecular Immunology, August 2016, Springer Science + Business Media

    yves Renaudineau

  86. Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up

    Article • Clinical Reviews in Allergy & Immunology, June 2016, Springer Science + Business Media

    yves Renaudineau

  87. Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises

    Article • Immunotherapy, May 2016, Future Medicine

    yves Renaudineau

  88. Defective DNA methylation in salivary gland epithelial acini from patients with Sjögren's syndrome is associated with SSB gene expression, anti-SSB/LA detection, and lymphocyte infiltration

    Article • Journal of Autoimmunity, April 2016, Elsevier

    yves Renaudineau

  89. Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia

    Article • OncoImmunology, March 2016, Taylor & Francis

    yves Renaudineau

  90. Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study

    Article • Annals of the Rheumatic Diseases, February 2016, BMJ

    yves Renaudineau

  91. B lymphocytes of chronic lymphocytic leukemia, regulatory B lymphocytes which ignore?

    Article • Hématologie, January 2016, John Libbey Eurotext

    yves Renaudineau

  92. Abatacept efficacy in rheumatoid arthritis is dependent upon baseline blood B-cell levels

    Article • Rheumatology, December 2015, Oxford University Press (OUP)

    yves Renaudineau

  93. An in silico Approach Reveals Associations between Genetic and Epigenetic Factors within Regulatory Elements in B Cells from Primary Sjögren’s Syndrome Patients

    Article • Frontiers in Immunology, August 2015, Frontiers

    yves Renaudineau

  94. Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis

    Article • Journal of Autoimmunity, July 2015, Elsevier

    yves Renaudineau

  95. AB0305 Pre-Treatment B-Cell Lymphopenia is Associated with a Low Response Rate to Abatacept in Patients with Rheumatoid Arthritis

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    yves Renaudineau

  96. Au-delà de nos gènes: la révolution de l’épigénétique

    Article • Revue Francophone des Laboratoires, June 2015, Elsevier

    yves Renaudineau

  97. FRI0280 Efficacy and Safety of Tocilizumab as First Line Therapy in Patients with Recent Polymyalgia Rheumatica (PMR): Results of the First Longitudinal Prospective Study (Tenor)

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    yves Renaudineau

  98. FRI0404 Disturbances of T and B Cell Homeostasis Characterized Primary Antiphospholipid Patients During their Follow-Up of Venous Thromboembolism

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    yves Renaudineau

  99. Épigénétique et médecine prédictive

    Article • Revue Francophone des Laboratoires, June 2015, Elsevier

    yves Renaudineau

  100. Ofatumumab capacity to deplete B cells from chronic lymphocytic leukaemia is affected by C4 complement exhaustion

    Article • European Journal Of Haematology, May 2015, Wiley

    yves Renaudineau

  101. Genetics and Epigenetics of Autoimmune Diseases

    Article • May 2015, Wiley

    yves Renaudineau

  102. Human Endogenous Retrovirus Group E and Its Involvement in Diseases

    Article • Viruses, March 2015, MDPI AG

    yves Renaudineau

  103. Epigenetics and autoimmune diseases: the X chromosome-nucleolus nexus

    Article • Frontiers in Genetics, February 2015, Frontiers

    yves Renaudineau

  104. A1.9 Among patients with venous thrombo-embolism, B cell subset disturbances characterise those with primary antiphospholipid syndrome

    Article • Annals of the Rheumatic Diseases, February 2015, BMJ

    yves Renaudineau

  105. A7.15 B-cell lymphopenia is associated with a low response rate to abatacept in patients with rheumatoid arthritis

    Article • Annals of the Rheumatic Diseases, February 2015, BMJ

    yves Renaudineau

  106. Annexin A2 autoantibodies in thrombosis and autoimmune diseases

    Article • Thrombosis Research, February 2015, Elsevier

    yves Renaudineau

  107. Calcium signaling and cell fate: how can Ca2+ signals contribute to wrong decisions for Chronic Lymphocytic Leukemic B lymphocyte outcome?

    Article • The International Journal of Developmental Biology, January 2015, UBC Press

    yves Renaudineau

  108. Endothelial Cell Autoreactivity and Infection

    Article • January 2015, Elsevier

    yves Renaudineau

  109. How the Environment Influences Epigenetics, DNA Methylation, and Autoimmune Diseases

    Article • January 2015, Elsevier

    yves Renaudineau

  110. Génomique, épigénétique et pathologies

    Article • Option/Bio, December 2014, Elsevier

    yves Renaudineau

  111. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis

    Article • Liver International, August 2014, Wiley

    yves Renaudineau, Professor DIMITRIOS P BOGDANOS

  112. The Differential Diagnosis of Dry Eyes, Dry Mouth, and Parotidomegaly: A Comprehensive Review

    Article • Clinical Reviews in Allergy & Immunology, June 2014, Springer Science + Business Media

    yves Renaudineau

  113. Salivary gland ultrasonography improves the diagnostic performance of the 2012 American College of Rheumatology classification criteria for Sjogren's syndrome

    Article • Rheumatology, April 2014, Oxford University Press (OUP)

    yves Renaudineau

  114. The contribution of epigenetics in Sjögren’s Syndrome

    Article • Frontiers in Genetics, April 2014, Frontiers

    yves Renaudineau

  115. Diagnostic criteria for autoimmune neutropenia

    Article • Autoimmunity Reviews, April 2014, Elsevier

    yves Renaudineau

  116. B cells display an abnormal distribution and an impaired suppressive function in patients with chronic antibody–mediated rejection

    Article • Kidney International, March 2014, Elsevier

    yves Renaudineau

  117. B1- and CD5-Positive B Cells

    Article • February 2014, Wiley

    yves Renaudineau

  118. A8.31 Characterisation of human transitional B-cells though their regulatory functions

    Article • Annals of the Rheumatic Diseases, January 2014, BMJ

    yves Renaudineau

  119. Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren’s syndrome

    Article • Arthritis Research & Therapy, January 2014, Springer Science + Business Media

    yves Renaudineau

  120. Glomerular Basement Membrane Autoantibodies

    Article • January 2014, Elsevier

    yves Renaudineau

  121. Level of agreement between 2002 American–European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome and reasons for discrepancies

    Article • Arthritis Research & Therapy, January 2014, Springer Science + Business Media

    yves Renaudineau

  122. Lymphocytotoxic Autoantibodies

    Article • January 2014, Elsevier

    yves Renaudineau

  123. Épigénétique et auto-immunité

    Article • Revue Francophone des Laboratoires, December 2013, Elsevier

    yves Renaudineau

  124. DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus

    Article • Autoimmunity, October 2013, Taylor & Francis

    yves Renaudineau

  125. MicroRNAs and multiple sclerosis: from physiopathology toward therapy

    Article • Expert Opinion on Therapeutic Targets, September 2013, Informa Healthcare

    yves Renaudineau

  126. B-Lymphocyte Signalling Abnormalities and Lupus Immunopathology

    Article • International Reviews of Immunology, June 2013, Taylor & Francis

    yves Renaudineau

  127. Aberrant B-lymphocyte responses in lupus: inherent or induced and potential therapeutic targets

    Article • European Journal of Clinical Investigation, May 2013, Wiley

    yves Renaudineau

  128. Rationale for treating primary Sjögren’s syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab)

    Article • Immunologic Research, April 2013, Springer Science + Business Media

    yves Renaudineau

  129. Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells

    Article • Journal of Autoimmunity, March 2013, Elsevier

    yves Renaudineau

  130. A5.1 Abnormal Calcium Influx in T and B Lymphocytes from Systemic Lupus Erythematosus Patients is Related to STIM-1 Over-Expression

    Article • Annals of the Rheumatic Diseases, February 2013, BMJ

    yves Renaudineau

  131. A7.8 DNA Demethylation in Salivary Gland Epithelial Cells from Patients with Primary Sjögren’s Syndrome may be Ascribed to Infiltrating B Cells

    Article • Annals of the Rheumatic Diseases, February 2013, BMJ

    yves Renaudineau

  132. Homozygous FCGR3A-158F mutation is associated with delayed B-cell depletion following rituximab but with preserved efficacy in a patient with refractory lupus nephritis

    Article • Clinical Kidney Journal, December 2012, Oxford University Press (OUP)

    yves Renaudineau

  133. Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden

    Article • Experimental and Molecular Pathology, December 2012, Elsevier

    Dr. Ori Barzilai, yves Renaudineau

  134. La présence d’anticorps anti-cellules HEK-293T caractérise les patients porteurs d’une glomérulonéphrite lupique active

    Article • Néphrologie & Thérapeutique, September 2012, Elsevier

    yves Renaudineau

  135. Altered patterns of epigenetic changes in systemic lupus erythematosus and auto-antibody production: Is there a link?

    Article • Journal of Autoimmunity, September 2012, Elsevier

    yves Renaudineau

  136. CD5 expression promotes multiple intracellular signaling pathways in B lymphocyte

    Article • Autoimmunity Reviews, September 2012, Elsevier

    yves Renaudineau

  137. Pierre Youinou: When intuition and determination meet autoimmunity

    Article • Journal of Autoimmunity, September 2012, Elsevier

    yves Renaudineau

  138. Epigenetics and Sjogren’s Syndrome

    Article • Current Pharmaceutical Biotechnology, July 2012, Bentham Science Publishers

    yves Renaudineau

  139. Mesangial Cell-Specific Antibodies Are Central to the Pathogenesis of Lupus Nephritis

    Article • Clinical and Developmental Immunology, January 2012, Hindawi Publishing Corporation

    yves Renaudineau

  140. Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy

    Article • Annals of Hematology, November 2011, Springer Science + Business Media

    yves Renaudineau

  141. Anti-α actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1

    Article • Alimentary Pharmacology & Therapeutics, November 2011, Wiley

    yves Renaudineau

  142. Les auto-anticorps adoptent maintes combinaisons au cours de l’hépatite auto-immune…

    Article • Immuno-analyse & Biologie Spécialisée, October 2011, Elsevier

    yves Renaudineau

  143. Epigenetic alterations and autoimmune disease

    Article • Journal of Developmental Origins of Health and Disease, August 2011, Cambridge University Press

    yves Renaudineau

  144. Intérêt des anticorps anti-prothrombine et des anticorps anti-phosphatidylsérine/prothrombine dans le bilan d’une thrombose

    Article • Immuno-analyse & Biologie Spécialisée, August 2011, Elsevier

    yves Renaudineau

  145. Quel est l’intérêt de la recherche des anticorps anti-nucléolaires dans la sclérodermie systémique ?

    Article • Immuno-analyse & Biologie Spécialisée, August 2011, Elsevier

    yves Renaudineau

  146. Quels auto-anticorps pour le diagnostic et le suivi de la néphropathie lupique ?

    Article • Immuno-analyse & Biologie Spécialisée, June 2011, Elsevier

    yves Renaudineau

  147. Auto-anticorps anti-membrane basale glomérulaire et syndrome de Goodpasture

    Article • Immuno-analyse & Biologie Spécialisée, April 2011, Elsevier

    yves Renaudineau

  148. CD5 Promotes IL-10 Production in Chronic Lymphocytic Leukemia B Cells through STAT3 and NFAT2 Activation

    Article • The Journal of Immunology, March 2011, The American Association of Immunologists

    yves Renaudineau

  149. Les ANCA (typiques ou non) en pratique médicale courante

    Article • Immuno-analyse & Biologie Spécialisée, February 2011, Elsevier

    yves Renaudineau

  150. CD5 Expression in B Cells from Patients with Systemic Lupus Erythematosus

    Article • Critical Reviews™ in Immunology, January 2011, Begell House

    yves Renaudineau

  151. DNA Methylation and B-Cell Autoreactivity

    Article • January 2011, Springer Science + Business Media

    yves Renaudineau

  152. Epigenetics and Autoimmunity, with Special Emphasis on Methylation

    Article • The Keio Journal of Medicine, January 2011, Keio Journal of Medicine

    yves Renaudineau

  153. Aberrant expression of CD6 on B-cell subsets from patients with Sjögren’s syndrome

    Article • Journal of Autoimmunity, December 2010, Elsevier

    yves Renaudineau

  154. Epigenetics in autoimmune disorders: Highlights of the 10th Sjögren's Syndrome Symposium

    Article • Autoimmunity Reviews, July 2010, Elsevier

    yves Renaudineau

  155. The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndrome

    Article • Arthritis & Rheumatism, June 2010, Wiley

    yves Renaudineau

  156. IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes

    Article • Blood, June 2010, American Society of Hematology

    yves Renaudineau

  157. Epigenetics and autoimmunity

    Article • Journal of Autoimmunity, May 2010, Elsevier

    yves Renaudineau

  158. Glomerular Antibodies in Lupus Nephritis

    Article • Clinical Reviews in Allergy & Immunology, April 2010, Springer Science + Business Media

    yves Renaudineau

  159. Pharmacological role and clinical applications of interleukin-6 in rheumatoid disease

    Article • International Journal of Interferon Cytokine and Mediator Research, April 2010, Taylor & Francis

    yves Renaudineau

  160. 1093 ANTI-α ACTININ ANTIBODIES ARE INDEPENDENT PREDICTORS OF RESPONSE TO TREATMENT IN AUTOIMMUNE HEPATITIS TYPE 1

    Article • Journal of Hepatology, April 2010, Elsevier

    yves Renaudineau

  161. Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of anti-endothelial cell antibodies

    Article • Rheumatology, March 2010, Oxford University Press (OUP)

    yves Renaudineau

  162. Endogenous retrovirus control is impaired in B cells from patients with systemic lupus erythematosus

    Article • Annals of the Rheumatic Diseases, March 2010, BMJ

    yves Renaudineau

  163. NFAT2 and STAT3 control type 2 cytokines in CD5 B cells

    Article • Annals of the Rheumatic Diseases, March 2010, BMJ

    yves Renaudineau

  164. Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases

    Article • Arthritis, February 2010, Hindawi Publishing Corporation

    yves Renaudineau

  165. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis

    Article • Journal of Autoimmunity, February 2010, Elsevier

    Dr. Ori Barzilai, yves Renaudineau

  166. Conference Scene: Updating the Highlights of SjöGren‘s Syndrome

    Article • Immunotherapy, December 2009, Taylor & Francis

    yves Renaudineau

  167. Intérêt de la TEP au FDG dans les lymphomes folliculaires

    Article • Cancer/Radiothérapie, October 2009, Elsevier

    yves Renaudineau

  168. Monoclonal anti-CD20 antibodies: Mechanisms of action and monitoring of biological effects

    Article • Joint Bone Spine, October 2009, Elsevier

    yves Renaudineau

  169. Mécanismes de l’action des anticorps monoclonaux anti-CD20 et surveillance biologique de leurs effets

    Article • Revue du Rhumatisme, October 2009, Elsevier

    yves Renaudineau

  170. IL-10 Production by B Cells Expressing CD5 with the Alternative Exon 1B

    Article • Annals of the New York Academy of Sciences, September 2009, Wiley

    yves Renaudineau

  171. New ELISA for B Cell-Activating Factor

    Article • Clinical Chemistry, August 2009, AACC

    yves Renaudineau

  172. Autoreactive B Cells and Epigenetics

    Article • Clinical Reviews in Allergy & Immunology, July 2009, Springer Science + Business Media

    yves Renaudineau

  173. The Revolution of Epigenetics in the Field of Autoimmunity

    Article • Clinical Reviews in Allergy & Immunology, July 2009, Springer Science + Business Media

    yves Renaudineau

  174. B lymphocyte cytokines and rheumatic autoimmune disease

    Article • Arthritis & Rheumatism, July 2009, Wiley

    yves Renaudineau

  175. Which autoantibodies announce that lupus nephritis is on the way?

    Article • International Journal of Clinical Rheumatology, June 2009, OMICS Publishing Group

    yves Renaudineau

  176. IL-6 Modulates CD5 Expression in B Cells from Patients with Lupus by Regulating DNA Methylation

    Article • The Journal of Immunology, April 2009, The American Association of Immunologists

    yves Renaudineau

  177. Les maladies inflammatoires chroniques de l’intestin : quels autoanticorps choisir ?

    Article • Immuno-analyse & Biologie Spécialisée, February 2009, Elsevier

    yves Renaudineau

  178. Purine-Rich Box-1-Mediated Reduced Expression of CD20 Alters Rituximab-Induced Lysis of Chronic Lymphocytic Leukemia B Cells

    Article • Cancer Research, September 2008, American Association for Cancer Research (AACR)

    yves Renaudineau

  179. Selection of the Alternative Exon 1 from the cd5 Gene Down-Regulates Membrane Level of the Protein in B Lymphocytes

    Article • The Journal of Immunology, July 2008, The American Association of Immunologists

    yves Renaudineau

  180. Intérêt des nouveaux examens sérologiques pour la néphropathie lupique

    Article • Immuno-analyse & Biologie Spécialisée, June 2008, Elsevier

    yves Renaudineau

  181. Anti-α-Actinin Antibodies Cross-react with Anti-ssDNA Antibodies in Active Autoimmune Hepatitis

    Article • Clinical Reviews in Allergy & Immunology, January 2008, Springer Science + Business Media

    yves Renaudineau

  182. Renal Involvement in Wegener’s Granulomatosis

    Article • Clinical Reviews in Allergy & Immunology, January 2008, Springer Science + Business Media

    yves Renaudineau

  183. The paradox of CD5-expressing B cells in systemic lupus erythematosus

    Article • Autoimmunity Reviews, December 2007, Elsevier

    yves Renaudineau

  184. Anticorps anti-C1q et anticorps anti-α-actinine: nouveaux marqueurs de la glomérulonéphrite lupique

    Article • Revue du Rhumatisme, November 2007, Elsevier

    yves Renaudineau

  185. Anti-alpha-actinin antibodies: A new marker of lupus nephritis

    Article • Autoimmunity Reviews, August 2007, Elsevier

    yves Renaudineau

  186. Anticorps anti-α-actinine et anticorps anti-C1q: deux nouveaux «marqueurs» pour la glomérulonéphrite lupique

    Article • Immuno-analyse & Biologie Spécialisée, June 2007, Elsevier

    yves Renaudineau

  187. Apport des nouveaux examens biologiques au diagnostic de la polyarthrite rhumatoïde

    Article • Immuno-analyse & Biologie Spécialisée, June 2007, Elsevier

    yves Renaudineau

  188. CD5 links humoral autoimmunity with B-cell chronic lymphocytic leukemia

    Article • Expert Review of Clinical Immunology, May 2007, Taylor & Francis

    yves Renaudineau

  189. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of RITUXIMAB-TREATED patients with Sjögren's syndrome

    Article • Arthritis & Rheumatism, January 2007, Wiley

    yves Renaudineau

  190. Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20)

    Article • Arthritis & Rheumatism, January 2007, Wiley

    yves Renaudineau

  191. LYMPHOCYTOTOXIC AUTOANTIBODIES

    Article • January 2007, Elsevier

    yves Renaudineau

  192. Les anticorps anti-ADN ne sont plus ce qu'ils étaient!… L'apport des nouvelles techniques de dépistag e au diagnostic du lupus érythémateux disséminé

    Article • Revue Francophone des Laboratoires, November 2006, Elsevier

    yves Renaudineau

  193. Les nouveaux ANCA : leur mode d'emploi

    Article • Immuno-analyse & Biologie Spécialisée, October 2006, Elsevier

    yves Renaudineau

  194. Double Reactivity Against Actin and α-Actinin Defines a Severe Form of Autoimmune Hepatitis Type 1

    Article • Journal of Clinical Immunology, September 2006, Springer Science + Business Media

    yves Renaudineau

  195. Le pourquoi et le commentde l'auto-immunité

    Article • Revue Francophone des Laboratoires, July 2006, Elsevier

    yves Renaudineau

  196. Les nouveaux autoanticorps du syndrome de Gougerot-Sjögren primaire

    Article • Immuno-analyse & Biologie Spécialisée, June 2006, Elsevier

    yves Renaudineau

  197. B lymphocytes on the front line of autoimmunity

    Article • Autoimmunity Reviews, March 2006, Elsevier

    yves Renaudineau

  198. Endothelium, a target for immune-mediated assault in connective tissue disease

    Article • Autoimmunity Reviews, March 2006, Elsevier

    yves Renaudineau

  199. Association of α-actinin–binding anti–double-stranded DNA antibodies with lupus nephritis

    Article • Arthritis & Rheumatism, January 2006, Wiley

    yves Renaudineau

  200. An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes

    Article • Blood, October 2005, American Society of Hematology

    yves Renaudineau

  201. Characterization of the human CD5 endogenous retrovirus-E in B lymphocytes

    Article • Genes & Immunity, August 2005, Springer Science + Business Media

    yves Renaudineau

  202. B Lymphocytes Are Required for Development and Treatment of Autoimmune Diseases

    Article • Annals of the New York Academy of Sciences, June 2005, Wiley

    yves Renaudineau

  203. The Anti-Alpha-Actinin Test Completes Anti-DNA Determination in Systemic Lupus Erythematosus

    Article • Annals of the New York Academy of Sciences, June 2005, Wiley

    yves Renaudineau

  204. B Cell Response to Surface IgM Cross-Linking Identifies Different Prognostic Groups of B-Chronic Lymphocytic Leukemia Patients

    Article • The Journal of Immunology, March 2005, The American Association of Immunologists

    yves Renaudineau

  205. Rheumatoid factor on a daily basis

    Article • Autoimmunity, February 2005, Taylor & Francis

    yves Renaudineau

  206. Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells

    Article • Leukemia, December 2004, Springer Science + Business Media

    yves Renaudineau

  207. Les lymphocytes B réhabilités : leur rôle est déterminant dans la genèse de l'auto-immunité

    Article • Immuno-analyse & Biologie Spécialisée, December 2004, Elsevier

    yves Renaudineau

  208. Dysfunctional B cells in systemic lupus erythematosus

    Article • Autoimmunity Reviews, November 2004, Elsevier

    yves Renaudineau

  209. Requirement for B lymphocytes in autoimmunity development

    Article • Autoimmunity Reviews, November 2004, Elsevier

    yves Renaudineau

  210. Apport des examens sérologiques au diagnostic de la polyarthrite rhumatoïde : les leçons du suivi de 270 malades pendant trois ans

    Article • Immuno-analyse & Biologie Spécialisée, October 2004, Elsevier

    yves Renaudineau

  211. The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases

    Article • Thrombosis Research, January 2004, Elsevier

    yves Renaudineau

  212. Effects of Anti-Endothelial Cell Antibodies in Leprosy and Malaria

    Article • Infection and Immunity, January 2004, ASM Journals

    yves Renaudineau

  213. CD5-Expressing B Cells and Infection

    Article • January 2004, Elsevier

    yves Renaudineau

  214. CD5-Expressing B Cells and Infection

    Article • January 2004, Elsevier

    yves Renaudineau

  215. Endothelial Cell Autoreactivity and Infection

    Article • January 2004, Elsevier

    yves Renaudineau

  216. Endothelial Cell Autoreactivity and Infection

    Article • January 2004, Elsevier

    yves Renaudineau

  217. Recurrence of ANCA-positive glomerulonephritis immediately after renal transplantation

    Article • American Journal of Kidney Diseases, October 2003, Elsevier

    yves Renaudineau

  218. Antiendothelial cell antibodies in systemic lupus erythematosus

    Article • Autoimmunity Reviews, December 2002, Elsevier

    yves Renaudineau

  219. Autoantibodies to heparan sulfate proteoglycans

    Article • Autoimmunity Reviews, October 2002, Elsevier

    yves Renaudineau

  220. Consequences of Fcγ receptor type III reactivity in non-organ-specific autoimmune diseases

    Article • Biochemical Society Transactions, August 2002, Portland Press Ltd.

    yves Renaudineau

  221. Pathogenic effects of anti-Fc gamma receptor IIIb (CD16) on polymorphonuclear neutrophils in non-organ-specific autoimmune diseases

    Article • Autoimmunity Reviews, February 2002, Elsevier

    yves Renaudineau

  222. Cross-Linking of Human Fc RIIIb Induces the Production of Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor by Polymorphonuclear Neutrophils

    Article • The Journal of Immunology, October 2001, The American Association of Immunologists

    yves Renaudineau

  223. Recent Progress in the Understanding of B-Cell Functions in Autoimmunity

    Article • Scandinavian Journal of Immunology, July 2001, Wiley

    yves Renaudineau

  224. Autoanticorps contre les polynucléaires neutrophiles au cours des maladies auto-immunes systémiques

    Article • La Revue de Médecine Interne, June 2001, Elsevier

    yves Renaudineau

  225. Functional heterogeneity of anti-endothelial cell antibodies

    Article • Clinical & Experimental Immunology, June 2001, Wiley

    yves Renaudineau

  226. Anti-Endothelial Cell Antibodies (AECA) in Systemic Sclerosis - Increased Sensitivity using Different Endothelial Cell Substrates and Association with Other Autoantibodies

    Article • Autoimmunity, January 2001, Taylor & Francis

    yves Renaudineau

  227. Characterization of murine monoclonal anti-endothelial cell antibodies (AECA) produced by idiotypic manipulation with human AECA

    Article • International Immunology, July 1998, Oxford University Press (OUP)

    yves Renaudineau

  228. Two populations of endothelial cell antibodies cross-react with heparin

    Article • Lupus, February 1998, SAGE Publications

    yves Renaudineau